Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2309548rdf:typepubmed:Citationlld:pubmed
pubmed-article:2309548lifeskim:mentionsumls-concept:C0007876lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C0021289lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C0013819lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C1858460lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C0020649lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C0014479lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2309548lifeskim:mentionsumls-concept:C1883073lld:lifeskim
pubmed-article:2309548pubmed:issue1lld:pubmed
pubmed-article:2309548pubmed:dateCreated1990-4-6lld:pubmed
pubmed-article:2309548pubmed:abstractTextThe recovery of 16 infants born by elective caesarean section with spinal anaesthesia, in which either ephedrine or fluid load was used to prevent maternal hypotension, were studied using Scanlon's neurobehavioural tests and a computerized EEG. Neurobehavioural testing showed no differences between the ephedrine and the non-ephedrine groups of infants at ages of 3 h, 1 day, 2 days and 4-5 days, whereas the spectral EEG showed significant differences between the two groups during the first 2 h after delivery, which had disappeared 24 h later. It is suggested that small doses of ephedrine given to the mother i.v. to prevent hypotension during spinal anaesthesia have short-lived effects on the neonate's central nervous system, which will be detected in the spectral EEG, but not in neurobehavioural tests.lld:pubmed
pubmed-article:2309548pubmed:languageenglld:pubmed
pubmed-article:2309548pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2309548pubmed:citationSubsetIMlld:pubmed
pubmed-article:2309548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2309548pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2309548pubmed:statusMEDLINElld:pubmed
pubmed-article:2309548pubmed:monthJanlld:pubmed
pubmed-article:2309548pubmed:issn0001-5172lld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:HuttunenPPlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:TolonenUUlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:JouppilaRRlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:KiveläAAlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:HollménA IAIlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:AlahuhtaSSlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:EskelinenPPlld:pubmed
pubmed-article:2309548pubmed:authorpubmed-author:Kangas-Saarel...lld:pubmed
pubmed-article:2309548pubmed:issnTypePrintlld:pubmed
pubmed-article:2309548pubmed:volume34lld:pubmed
pubmed-article:2309548pubmed:ownerNLMlld:pubmed
pubmed-article:2309548pubmed:authorsCompleteYlld:pubmed
pubmed-article:2309548pubmed:pagination8-16lld:pubmed
pubmed-article:2309548pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:meshHeadingpubmed-meshheading:2309548-...lld:pubmed
pubmed-article:2309548pubmed:year1990lld:pubmed
pubmed-article:2309548pubmed:articleTitleDoes ephedrine influence newborn neurobehavioural responses and spectral EEG when used to prevent maternal hypotension during caesarean section?lld:pubmed
pubmed-article:2309548pubmed:affiliationDepartment of Anaesthesiology, University of Oulu, Finland.lld:pubmed
pubmed-article:2309548pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2309548pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:2309548pubmed:publicationTypeRandomized Controlled Triallld:pubmed